Sayuri Minowa
Overview
Explore the profile of Sayuri Minowa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shirouchi Y, Mishima Y, Takayama T, Minowa S, Ishihara Y, Tamba M, et al.
Biomed Res
. 2022 Aug;
43(4):99-106.
PMID: 35989290
Cell-free DNA (cfDNA) is a fragment of DNA circulating in the blood, and its concentration is often elevated in cancer patients. To investigate the relationships between serum cfDNA concentration and...
2.
Mishima Y, Matsusaka S, Chin K, Mikuniya M, Minowa S, Takayama T, et al.
Target Oncol
. 2017 May;
12(3):341-351.
PMID: 28508152
A key to the successful use of targeted cancer therapy is the ability to preselect patients who are likely to benefit from the treatment according to molecular markers. Assessment for...
3.
Matsusaka S, Kozuka M, Takagi H, Ito H, Minowa S, Hirai M, et al.
Cancer Lett
. 2014 Sep;
355(1):113-20.
PMID: 25218346
Most circulating tumor cell (CTC) detection methods have technical limitations, allowing the detection of only cells expressing epithelial antigens, and they cannot identify if the CTCs are alive or dead....
4.
Kuboki Y, Matsusaka S, Minowa S, Shibata H, Suenaga M, Shinozaki E, et al.
Anticancer Res
. 2013 Sep;
33(9):3905-10.
PMID: 24023327
Background/aim: The purpose of this study was to establish whether CTC count and epidermal growth factor receptor (EGFR) expression in CTCs predicted outcome in patients with advance colorectal cancer (ACC)...
5.
Mitsuhashi J, Tsukahara S, Suzuki R, Oh-hara Y, Nishi S, Hosoyama H, et al.
Hum Gene Ther
. 2007 Oct;
18(10):895-906.
PMID: 17907967
A clinical study of an MDR1 gene therapy protocol targeting metastatic breast cancer has been conducted in which the patients received high-dose chemotherapy, a transplant of MDR1-transduced autologous CD34(+) cells,...
6.
Takahashi S, Aiba K, Ito Y, Hatake K, Nakane M, Kobayashi T, et al.
Cancer Sci
. 2007 Aug;
98(10):1609-16.
PMID: 17683514
A major problem in high-dose chemotherapy with autologous hematopoietic stem cell transplantation is insufficient function of reconstituted bone marrow that limits the efficacy of post-transplantation chemotherapy. Because transduction of hematopoietic...